Page last updated: 2024-08-24

goralatide and Cardiac Failure

goralatide has been researched along with Cardiac Failure in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cuculich, P; Lenihan, DJ	1
Merali, S; Sherwi, N; Wong, K	1
Lipsic, E; Schoemaker, RG; van de Wal, RM; van der Meer, P; van Gilst, WH; van Veldhuisen, DJ; Vellenga, E; Voors, AA; Westenbrink, BD	1
Ezan, E; Fraser, C; Junot, C; MacFadyen, R; Morton, JJ; Robson, J; Struthers, AD	1

Reviews

1 review(s) available for goralatide and Cardiac Failure

Article	Year
Personalizing biomarker strategies in heart failure with galectin-3. Future cardiology, 2012, Volume: 8, Issue:6 Topics: Biomarkers; Fibrosis; Galectin 3; Heart Failure; Humans; Oligopeptides; Prognosis; Translational Research, Biomedical; Ventricular Remodeling	2012

Trials

1 trial(s) available for goralatide and Cardiac Failure

Article	Year
Nonadherence with angiotensin-converting enzyme inhibitor therapy: a comparison of different ways of measuring it in patients with chronic heart failure. Journal of the American College of Cardiology, 1999, Volume: 34, Issue:7 Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Chronic Disease; Diuretics; Drug Therapy, Combination; Echocardiography; Furosemide; Heart Failure; Humans; Lisinopril; Oligopeptides; Peptidyl-Dipeptidase A; Radionuclide Ventriculography; Treatment Outcome; Treatment Refusal	1999

Article

Year

Nonadherence with angiotensin-converting enzyme inhibitor therapy: a comparison of different ways of measuring it in patients with chronic heart failure.

Journal of the American College of Cardiology, 1999, Volume: 34, Issue:7

Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Chronic Disease; Diuretics; Drug Therapy, Combination; Echocardiography; Furosemide; Heart Failure; Humans; Lisinopril; Oligopeptides; Peptidyl-Dipeptidase A; Radionuclide Ventriculography; Treatment Outcome; Treatment Refusal

1999

Other Studies

2 other study(ies) available for goralatide and Cardiac Failure

Article	Year
Cardioprotection During Therapeutic Radiation Treatment. Circulation. Heart failure, 2018, Volume: 11, Issue:8 Topics: Cardiomyopathies; Cardiotoxicity; Heart Failure; Humans; Oligopeptides; Peptides	2018
Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation, 2005, Sep-20, Volume: 112, Issue:12 Topics: Aged; Anemia; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Echocardiography; Female; Glomerular Filtration Rate; Growth Inhibitors; Heart Failure; Hematopoiesis; Humans; Male; Myocardial Ischemia; Oligopeptides; Peptidyl-Dipeptidase A; Reference Values; Ventricular Function, Left	2005

Article

Year

Cardioprotection During Therapeutic Radiation Treatment.

Circulation. Heart failure, 2018, Volume: 11, Issue:8

Topics: Cardiomyopathies; Cardiotoxicity; Heart Failure; Humans; Oligopeptides; Peptides

2018

Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure.

Circulation, 2005, Sep-20, Volume: 112, Issue:12

Topics: Aged; Anemia; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Echocardiography; Female; Glomerular Filtration Rate; Growth Inhibitors; Heart Failure; Hematopoiesis; Humans; Male; Myocardial Ischemia; Oligopeptides; Peptidyl-Dipeptidase A; Reference Values; Ventricular Function, Left

2005